Table 2
Summary of trials investigating incidence of HBV reactivation after rituximab treatment
Abbreviations: (−), negative; (+), positive; anti-HBc, antibody to hepatitis B core antigen; anti-HBs, antibody to hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; NR, not reported.
Table 2
Summary of trials investigating incidence of HBV reactivation after rituximab treatment
Abbreviations: (−), negative; (+), positive; anti-HBc, antibody to hepatitis B core antigen; anti-HBs, antibody to hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; NR, not reported.
